Efficacy of confrontational counselling for smoking cessation in smokers with previously undiagnosed mild to moderate airflow limitation: study protocol of a randomized controlled trial-0

<p><b>Copyright information:</b></p><p>Taken from "Efficacy of confrontational counselling for smoking cessation in smokers with previously undiagnosed mild to moderate airflow limitation: study protocol of a randomized controlled trial"</p><p>http://www.biomedcentral.com/1471-2458/7/332</p><p>BMC Public Health 2007;7():332-332.</p><p>Published online 15 Nov 2007</p><p>PMCID:PMC2234415.</p><p></p

Efficacy of confrontational counselling for smoking cessation in smokers with previously undiagnosed mild to moderate airflow limitation: study protocol of a randomized controlled trial-2

<p><b>Copyright information:</b></p><p>Taken from "Efficacy of confrontational counselling for smoking cessation in smokers with previously undiagnosed mild to moderate airflow limitation: study protocol of a randomized controlled trial"</p><p>http://www.biomedcentral.com/1471-2458/7/332</p><p>BMC Public Health 2007;7():332-332.</p><p>Published online 15 Nov 2007</p><p>PMCID:PMC2234415.</p><p></p

Efficacy of confrontational counselling for smoking cessation in smokers with previously undiagnosed mild to moderate airflow limitation: study protocol of a randomized controlled trial-1

<p><b>Copyright information:</b></p><p>Taken from "Efficacy of confrontational counselling for smoking cessation in smokers with previously undiagnosed mild to moderate airflow limitation: study protocol of a randomized controlled trial"</p><p>http://www.biomedcentral.com/1471-2458/7/332</p><p>BMC Public Health 2007;7():332-332.</p><p>Published online 15 Nov 2007</p><p>PMCID:PMC2234415.</p><p></p

Additional file 1: of Experiences of tobacco smoking and quitting in smokers with and without chronic obstructive pulmonary disease-a qualitative analysis

Interview topic guide. (DOCX 17 kb

The structure of two pyrazole esters related to Rimonabant

Two 1,5-diarylpyrazoles related to the antiobesity agent Rimonabant have been synthesized and their structure determined by X-ray crystallography. Compound 2, 1-(2,4-dichlorophenyl)-5-(4-chlorophenyl)- 4-methyl-1H-pyrazole-3-carboxylate, forms strange crystals but its only peculiarity involves Cl Cl and Cl p interactions, that were modeled theoretically at the M05-2x/6-31+G(d,p) level. 13C NMRresults were rationalized through GIAO calculations at the B3LYP/6-311+G(d,p) computational level.This work was carried out with financial support from the Ministerio de Educación y Ciencia (Project No. CTQ2007-62113 and 61901/BQU) and Comunidad Autónoma de Madrid (Project MADRISOLAR, ref. S-0505/PPQ/0225). Mario Alvarado acknowledges a Grant from RETICS RD06/001/0014 (Instituto de Salud Carlos III). S.G.-G. gratefully acknowledges the financial support from MEC, projects MAT2006-01997 and Consolider Ingenio-2010, ‘Factoría Española de CristalizaciónPeer reviewe